- Home
- PFO vs ALTS Comparison
PFO vs ALTS Comparison
Compare PFO & ALTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFO
- ALTS
- Stock Information
- Founded
- PFO 1991
- ALTS 1976
- Country
- PFO United States
- ALTS United States
- Employees
- PFO N/A
- ALTS N/A
- Industry
- PFO Finance Companies
- ALTS
- Sector
- PFO Finance
- ALTS
- Exchange
- PFO Nasdaq
- ALTS NYSE
- Market Cap
- PFO 120.4M
- ALTS 103.4M
- IPO Year
- PFO N/A
- ALTS N/A
- Fundamental
- Price
- PFO $8.92
- ALTS $6.10
- Analyst Decision
- PFO
- ALTS
- Analyst Count
- PFO 0
- ALTS 0
- Target Price
- PFO N/A
- ALTS N/A
- AVG Volume (30 Days)
- PFO 31.8K
- ALTS 144.1K
- Earning Date
- PFO 01-01-0001
- ALTS 05-16-2025
- Dividend Yield
- PFO 6.51%
- ALTS N/A
- EPS Growth
- PFO N/A
- ALTS N/A
- EPS
- PFO N/A
- ALTS N/A
- Revenue
- PFO N/A
- ALTS $12,532,000.00
- Revenue This Year
- PFO N/A
- ALTS N/A
- Revenue Next Year
- PFO N/A
- ALTS N/A
- P/E Ratio
- PFO N/A
- ALTS N/A
- Revenue Growth
- PFO N/A
- ALTS N/A
- 52 Week Low
- PFO $6.90
- ALTS $1.29
- 52 Week High
- PFO $8.51
- ALTS $7.75
- Technical
- Relative Strength Index (RSI)
- PFO 55.45
- ALTS 60.29
- Support Level
- PFO $8.71
- ALTS $5.50
- Resistance Level
- PFO $8.90
- ALTS $6.24
- Average True Range (ATR)
- PFO 0.10
- ALTS 0.61
- MACD
- PFO 0.03
- ALTS 0.03
- Stochastic Oscillator
- PFO 94.12
- ALTS 48.26
About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated
Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end management investment company. Its primary investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.
About ALTS ALT5 SIGMA CORPORATION
ALT5 Sigma Corp is a fintech company. The company operates in three operating segments: Fintech: provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, Biotechnology: Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties; Corporate and Others: Corporate and Other segment consists of certain corporate general and administrative costs. Company has revenue from Fintech Segment.